Risk of Future Cardiovascular Events Stratified by COVID-19 Severity
A study was conducted to determine the relationship between COVID-19 severity and risk for cardiovascular events 30 days following diagnosis.
A study was conducted to determine the relationship between COVID-19 severity and risk for cardiovascular events 30 days following diagnosis.
Early administration of sotrovimab may achieve more rapid decline in viral load, according to investigators.
Vaccination decreased the risk for COVID-related hospitalization and death, according to a retrospective study.
Appropriate use of remdesivir in patients with COVID-19 who are on hemodialysis may not result in a high risk of side effects, such as hepatotoxicity, according to investigators.
Understanding immune signatures of kidney transplant recipients during and after COVID-19 infection may provide insight into management.
Investigators hypothesize that patients presented later to their health care providers during the first year of the pandemic.
New findings provide a rationale for reexamining the hepatitis C virus penalty assigned by the Kidney Donor Profile Index, which is used to indicate the quality of deceased-donor kidneys.
The monoclonal antibody combination retained a neutralizing activity against the Omicron variants BA.1, and BA.2 in kidney transplant recipients.
Observational study findings highlight a “persistent and marked” association between hypertension and risk for severe COVID-19, even among fully vaccinated patients, according to investigators.
Despite their immunocompromised status, patients on hemodialysis might have a memory B cell response similar to that of the general population, according to investigators.